Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Organ Transplant Start-Up Gains $38M in Early Funds

A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round. . . . → Read More: Organ Transplant Start-Up Gains $38M in Early Funds

Medical Robotics Company Crowdfunding IPO

A medical robotics company spun-off from labs at MIT is issuing its initial public stock offering through equity crowdfunding, aiming to raise $15 million. . . . → Read More: Medical Robotics Company Crowdfunding IPO

Cancer Blood Test Company Raises $65M in Early Funds

Freenome, a company applying machine learning to analysis of liquid biopsies, is raising $65 million in its first round of venture financing. . . . → Read More: Cancer Blood Test Company Raises $65M in Early Funds

Duchenne Gene-Editing Company Launched, Raising $5M

A biotechnology start-up is applying a process for editing-out disease-causing mutations to correct the inherited disorder Duchenne muscular dystrophy. . . . → Read More: Duchenne Gene-Editing Company Launched, Raising $5M

Tissue Regeneration Start-Up Gains $33M in Early Funds

A new enterprise founded by researchers at Stanford University aims to discover and develop drugs that repair and regenerate tissue from stem cells. . . . → Read More: Tissue Regeneration Start-Up Gains $33M in Early Funds

Ford Investing $1B in Artificial Intelligence Start-Up

Ford Motor Company is investing $1 billion in a start-up enterprise that applies artificial intelligence to the operation and management of autonomous vehicles. . . . → Read More: Ford Investing $1B in Artificial Intelligence Start-Up

Biotechs License Solid Tumor Therapy in $2.1B Deal

Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs. . . . → Read More: Biotechs License Solid Tumor Therapy in $2.1B Deal

Protein Drug Discovery Company Launches, Gains $50M

A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins. . . . → Read More: Protein Drug Discovery Company Launches, Gains $50M

Immunotherapy Biotech Raises $102 Million in IPO

A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering. . . . → Read More: Immunotherapy Biotech Raises $102 Million in IPO

Allergy Immunotherapy Firm Raises $2M in Early Funds

A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round. . . . → Read More: Allergy Immunotherapy Firm Raises $2M in Early Funds